Sanofi initiates voluntary recall of Allegra, Combiflam suspensions due to contamination in some batches

Sanofi has announced a "temporary halt" on the sales of Allegra Suspension and Combiflam Suspension in India, due to microbiological contamination. The precautionary recall, affecting specific batches, aims to ensure safety while investigations continue. These medicines, commonly used for treating allergies and pain in children, are being recalled from distributors, hospitals, and retailers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NDdXI9r
via IFTTT